Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03899077
Title Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP (SAVE)
Acronym SAVE
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Cancer Research Antwerp
Indications
Therapies
Age Groups: senior | adult
Covered Countries BEL


No variant requirements are available.